Literature DB >> 21985247

Clozapine and associated QTc prolongation.

Rohan Dhillon, Tarun Bastiampillai, Kristen Tee, Andrew Vanlint.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21985247     DOI： 10.3109/00048674.2011.619163

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN： 0004-8674            Impact factor:   5.744


× No keyword cloud information.
  5 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

Review 2.  Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review.

Authors:  Hiroyoshi Takeuchi; Takefumi Suzuki; Gary Remington; Hiroyuki Uchida
Journal:  Can J Psychiatry       Date:  2015-05       Impact factor: 4.356

Review 3.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

Review 4.  Review of withdrawal catatonia: what does this reveal about clozapine?

Authors:  Matthew Lander; Tarun Bastiampillai; Jitender Sareen
Journal:  Transl Psychiatry       Date:  2018-07-31       Impact factor: 6.222

5.  Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study.

Authors:  Nobuyuki Nomura; Kohei Kitagawa; Ryuhei So; Fuminari Misawa; Masafumi Kodama; Hiroyoshi Takeuchi; Robert Bies; Thomas Straubinger; Christopher Banker; Yuya Mizuno; Masaru Mimura; Hiroyuki Uchida
Journal:  Ther Adv Psychopharmacol       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.